Cogent Biosciences, Inc. · NASDAQ:COGT
Paradigm Biocapital Advisors LP reported a 9.10% stake in Cogent Biosciences, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Paradigm Biocapital Advisors LP reported a 9.10% stake in Cogent Biosciences, Inc., 10,352,449 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.10%
- Shares
- 10,352,449
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Paradigm BioCapital Advisors LP | 9.10% | 10,352,449 |
| Paradigm BioCapital Advisors GP LLC | 9.10% | 10,352,449 |
| Senai Asefaw, M.D. | 9.10% | 10,352,449 |
| Paradigm BioCapital International Fund Ltd. | 8.10% | 9,169,832 |
Source
Related
- Cogent Biosciences, Inc.
- Paradigm Biocapital Advisors LP
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Nov 14, 2025
- Schedule 13G/A · Paradigm Biocapital Advisors LP · May 15, 2025
- Schedule 13G · Paradigm Biocapital Advisors LP · Feb 12, 2025
- Form 4 · Morris Arlene · Aug 31, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Robbins Andrew R · May 21, 2026